Cocoa Flavanols (Theobroma cacao Extract)
Cocoa flavanols are the flavan-3-ol polyphenols of the cocoa bean (Theobroma cacao): the building block (-)-epicatechin, a little catechin, and short chains of these units called procyanidins. Supplements concentrate them into an extract, because ordinary cocoa products vary widely and alkali (Dutch) processing strips out most of the flavanols. In short trials, flavanol-rich cocoa lowered blood pressure slightly (about 2 mmHg on average) and improved flow-mediated dilation, a measure of how well arteries widen. The largest trial, COSMOS (21,442 older US adults given 500 mg flavanols a day or placebo for a median 3.6 years), did not significantly reduce its main outcome of total cardiovascular events; fewer cardiovascular deaths were a secondary finding. COSMOS studies of memory and thinking found no overall benefit. Compare products by milligrams of flavanols, not milligrams of extract.
Benefits
Blood pressure in short-term trials
A Cochrane review of 35 randomized trials (1,804 mainly healthy adults, 2 to 18 weeks, chocolate or cocoa products) found about 1.8 mmHg lower systolic and diastolic pressure, rated moderate-quality evidence. A wider analysis of 145 trials of flavan-3-ol foods found about 2.8/2.0 mmHg. In COSMOS, a median 3.4 years of cocoa extract did not lower the overall rate of new high blood pressure.
Blood vessel function (flow-mediated dilation)
Flow-mediated dilation measures how well an artery widens. A meta-analysis of 18 trial arms found cocoa flavanols raised it by 1.17% on average, with the largest effect near 710 mg a day, though most studies had risk-of-bias concerns. A 1-month drink trial in 100 healthy adults (450 mg twice daily) found a similar gain. The EU accepts 200 mg a day for helping maintain blood vessel elasticity.
Long-term heart outcomes in older adults (COSMOS)
COSMOS gave 21,442 older US adults a cocoa extract capsule (500 mg flavanols a day) or placebo for a median 3.6 years. Its main outcome, total cardiovascular events, was not significantly reduced (hazard ratio 0.90, P = 0.11). As a secondary outcome, cardiovascular deaths were 27% lower; heart attack, stroke and death from any cause did not differ significantly. Mars Edge partly funded the trial and supplied the capsules.
Memory and thinking in older adults
Three COSMOS studies at 500 mg flavanols a day found no overall gain in cognition: 2,262 people tested by phone for 3 years and 573 tested in person for 2 years. In 3,562 people the main 1-year memory result was not significant; memory improved only in those with lower habitual diet quality or flavanol intake, a subgroup finding. A smaller 8-week drink trial in 90 older adults reported better scores on some tests.
Cholesterol and blood sugar markers
Results are inconsistent. A 1-month drink trial in 100 healthy adults lowered LDL cholesterol by 0.17 mmol/L and raised HDL by 0.10 mmol/L, and a 1-month capsule trial in 45 young men lowered total cholesterol, but a 4-week capsule trial in 75 young adults found no lipid change. For blood sugar, COSMOS found no reduction in new type 2 diabetes among 18,381 people over 3.5 years.
Mechanism of action
Epicatechin and nitric oxide in the artery lining
Cocoa flavanols are thought to increase nitric oxide made by the artery lining, which relaxes blood vessels. In a 1-month capsule trial in 45 young men, an extract with 130 mg epicatechin plus procyanidins improved flow-mediated dilation and blood pressure, while one with mostly procyanidins (20 mg epicatechin) did not; the gain tracked blood levels of epicatechin metabolites.
Procyanidins and blood lipids
In the same capsule trial, total cholesterol fell with both the epicatechin-rich and the procyanidin-rich extract, suggesting the longer procyanidin chains, not epicatechin alone, drove that change. This is one small trial in young men.
Theobromine and caffeine come along with the extract
Cocoa extracts also contain methylxanthines. The COSMOS capsules supplied about 50 mg theobromine and 15 mg caffeine a day, and the investigators note they cannot separate these from the flavanols. A 4-week trial testing epicatechin, methylxanthines or both in young adults found no effect on arterial stiffness from any of them.
Clinical trials
Randomized, double-blind, placebo-controlled 2-by-2 factorial trial of a cocoa extract capsule (500 mg flavanols a day, including 80 mg epicatechin) and a multivitamin; median follow-up 3.6 years. Funded in part by Mars Edge, which supplied the capsules (Sesso et al. 2022, Am J Clin Nutr)
21,442 US adults free of major cardiovascular disease (12,666 women aged 65 or older and 8,776 men aged 60 or older).
Total cardiovascular events, the primary outcome, were not significantly reduced: 410 on cocoa extract vs 456 on placebo (hazard ratio 0.90, 95% CI 0.78 to 1.02, P = 0.11). Among secondary outcomes, cardiovascular death was lower (hazard ratio 0.73, 0.54 to 0.98), while heart attack, stroke and all-cause death did not differ significantly. A per-protocol analysis limited to adherent participants gave a hazard ratio of 0.85, but this breaks randomization. No safety concerns were found.
Cochrane systematic review and meta-analysis of randomized trials lasting at least 2 weeks comparing flavanol-rich chocolate or cocoa products with flavanol-free or low-flavanol controls (Ried et al. 2017, Cochrane Database Syst Rev)
1,804 mainly healthy adults in 35 trials (40 comparisons), given 30 to 1,218 mg flavanols a day (mean 670 mg) for 2 to 18 weeks.
Systolic and diastolic pressure were each about 1.76 mmHg lower than control, rated moderate-quality evidence. Systolic pressure fell about 4 mmHg in people with high blood pressure but not significantly in those with normal pressure (subgroup difference P = 0.08). Removing trials with industry-employed authors shrank the effect slightly. Gut complaints or nausea affected about 1% on cocoa vs 0.4% on control.
Systematic review and dose-response meta-analysis of randomized trials measuring flow-mediated dilation after cocoa flavanol intake; authors from the Nestle Research Centre (Sun et al. 2019, Food Funct)
15 published studies with 18 intervention arms; active groups received 80 to 1,248 mg (mean 704 mg) more flavanols than controls.
Flow-mediated dilation improved by 1.17% (95% CI 0.76 to 1.57). The dose-response curve was an inverted U, with the largest effect near 710 mg total flavanols (about 95 mg epicatechin) a day. Much of the variation between studies was unexplained, and most studies had risk-of-bias concerns.
Randomized, controlled, double-masked, parallel-group trial of a cocoa flavanol drink (450 mg) or a nutrient-matched flavanol-free drink twice daily for 1 month; one co-author was affiliated with Mars (Sansone et al. 2015, Br J Nutr)
100 healthy men and women aged 35 to 60 with no cardiovascular disease.
Flow-mediated dilation, the primary outcome, rose by 1.2% over control (95% CI 1.0 to 1.4). Blood pressure fell by 4.4/3.9 mmHg, LDL cholesterol by 0.17 mmol/L and total cholesterol by 0.20 mmol/L, while HDL rose by 0.10 mmol/L. This tested a drink, not a capsule, and lasted only a month.
Randomized, controlled, double-masked, parallel-group trial of two cocoa extract capsules and a flavanol-free control capsule taken once daily for 1 month; two co-authors were affiliated with Mars (Rodriguez-Mateos et al. 2018, Am J Clin Nutr)
45 healthy men aged 18 to 35.
The extract with 130 mg epicatechin and 560 mg procyanidins increased flow-mediated dilation (the primary outcome) and lowered pulse wave velocity and blood pressure; the extract with 20 mg epicatechin and 540 mg procyanidins did not. Total cholesterol fell with both extracts. The authors link the vascular effect mainly to epicatechin.
Randomized, placebo-controlled 5-arm trial of daily capsules for 4 weeks: flavanol-rich cocoa powder (at least 200 mg flavanols), epicatechin, methylxanthines, epicatechin plus methylxanthines, or placebo (Weigant et al. 2025, Mol Nutr Food Res)
75 healthy young nonsmoking adults (15 per group).
No group changed aortic pulse wave velocity (P = 0.410), blood pressure, endothelin-1 or blood lipids compared with placebo. The cocoa dose matched the amount in the EU blood vessel elasticity claim, and the groups were small.
Randomized, placebo-controlled 2-by-2 factorial 3-year trial of cocoa extract (500 mg flavanols a day) and a multivitamin, with cognition tested by telephone each year (Baker et al. 2023, Alzheimers Dement)
2,262 older US adults (mean age 73, 60% women).
Cocoa extract had no effect on the primary global cognition score (mean z-score 0.03, 95% CI -0.02 to 0.08, P = 0.28). The multivitamin arm, a secondary comparison, showed a small benefit; cocoa did not.
Randomized, placebo-controlled study within COSMOS of cocoa extract (500 mg flavanols a day) for up to 3 years, with a urine flavanol biomarker in a subset; two authors were Mars employees and two received a Mars research grant (Brickman et al. 2023, Proc Natl Acad Sci U S A)
3,562 older adults; biomarker measured in 1,361.
The prespecified primary outcome, a memory gain in all participants after 1 year, was not statistically significant. Memory improved in participants in the lower thirds of habitual diet quality or flavanol intake, and rises in the flavanol biomarker tracked memory gains. These subgroup results need confirmation.
Side effects and drug interactions
Common Potential side effects
Important Drug interactions
Frequently asked questions about Cocoa Flavanols (Theobroma cacao Extract)
Can I get the same flavanols from dark chocolate or cocoa powder?
Not reliably. Flavanol content depends on how much cocoa solids a product contains and how it was processed. In a survey of US products, cocoa powder had the most epicatechin and catechin per gram, then baking chocolate, then dark chocolate, with milk chocolate and syrup lowest. Alkali (Dutch) processing cuts flavanols sharply: natural cocoa powders averaged 34.6 mg per gram and heavily alkalized ones 3.9 mg. Chocolate also adds sugar, fat and calories.
How much cocoa flavanol do studies use?
COSMOS used 500 mg cocoa flavanols a day (including 80 mg epicatechin) in two capsules. Blood pressure trials used 30 to 1,218 mg a day, averaging 670 mg, and one dose-response analysis found the largest blood vessel effect near 710 mg a day. The EU blood vessel elasticity claim is based on 200 mg a day. Look for mg of flavanols on the label; mg of cocoa extract or percent polyphenols is not the same thing.
Will cocoa flavanols improve my memory?
The large trials say probably not for most people. In COSMOS, 500 mg flavanols a day for 2 to 3 years did not improve overall cognition in two studies (2,262 and 573 older adults), and a third study of 3,562 people missed its main memory outcome. Memory improved only in people whose usual diet was low in flavanols or lower in quality, which still needs confirming.
Do cocoa flavanol supplements contain caffeine?
A little. Cocoa naturally contains theobromine and caffeine. The COSMOS daily dose had about 50 mg theobromine and 15 mg caffeine. Extracts standardized for theobromine rather than flavanols, such as Chocamine, are a different kind of product.
How do the branded cocoa extracts relate to this page?
CocoaVia, CocoaNol, CocoaGanic and Cocoamind are branded cocoa flavanol extracts, each with its own page. Most of the research here used specific cocoa drinks or the COSMOS capsule, so compare brands by the flavanol and epicatechin milligrams they state per serving rather than by brand claims. goCOCOA, despite the name, is a cocoa butter powder used for flavor and texture, not a flavanol extract.
What is Cocoa Flavanols?
Cocoa flavanols are the flavan-3-ol polyphenols of the cocoa bean (Theobroma cacao): the building block (-)-epicatechin, a little catechin, and short chains of these units called procyanidins.
What is Cocoa Flavanols used for?
Cocoa Flavanols is researched primarily for Cardiovascular. A Cochrane review of 35 randomized trials (1,804 mainly healthy adults, 2 to 18 weeks, chocolate or cocoa products) found about 1.8 mmHg lower systolic and diastolic pressure, rated moderate-quality evidence.
Is Cocoa Flavanols safe, and does it have side effects?
Side effects and cautions reported for Cocoa Flavanols include: Usually well tolerated. In Cosmos (median 3.6 years) there were no safety concerns; the cocoa extract group reported nausea slightly more often than placebo (hazard ratio 1.06), and headaches and migraine slightly less often. It may also interact with some medications. Cocoa Flavanols is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.
Does Cocoa Flavanols interact with any medications?
Possible interactions include: Blood pressure medicines: cocoa flavanols lowered blood pressure slightly in trials, a little more in people with high blood pressure, so a small additive effect is possible. Do not replace prescribed treatment; tell your doctor. If you take prescription medication, check with a pharmacist or doctor before using it.
How strong is the scientific evidence for Cocoa Flavanols?
NutraSmarts rates the evidence for Cocoa Flavanols as Moderate (3 out of 5). It is backed by 8 study summaries and 16 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.
References(16 citations)
Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.
- Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial. Am J Clin Nutr. 2022;115(6):1490-1500. doi: 10.1093/ajcn/nqac055.PubMedUsed to support: COSMOS randomized trial in 21,442 older US adults: cocoa extract with 500 mg flavanols a day for a median 3.6 years did not significantly reduce total cardiovascular events (HR 0.90, P = 0.11). Cardiovascular death, a secondary outcome, was 27% lower (HR 0.73). Supported by Mars Edge, which supplied the capsules.
- Effect of cocoa on blood pressure. Cochrane Database Syst Rev. 2017;4(4):CD008893. doi: 10.1002/14651858.CD008893.pub3.PubMedUsed to support: Cochrane review of 35 randomized trials (1,804 mainly healthy adults, 2 to 18 weeks): flavanol-rich cocoa products lowered systolic and diastolic blood pressure by about 1.76 mmHg, moderate-quality evidence. Larger effect in people with high blood pressure (subgroup of borderline significance).
- Impact of flavan-3-ols on blood pressure and endothelial function in diverse populations: a systematic review and meta-analysis of randomized controlled trials. Eur J Prev Cardiol. 2025;32(14):1322-1334. doi: 10.1093/eurjpc/zwaf173.PubMedUsed to support: Meta-analysis of 145 randomized trials (5,205 people) of flavan-3-ol foods, drinks and supplements (cocoa, tea, grape, apple, pure compounds): office blood pressure about 2.8/2.0 mmHg lower and flow-mediated dilation higher, with larger blood pressure effects at higher baseline pressure. Not limited to cocoa; one co-author worked for Unilever and one for Lipton.
- Dose-response relationship between cocoa flavanols and human endothelial function: a systematic review and meta-analysis of randomized trials. Food Funct. 2019;10(10):6322-6330. doi: 10.1039/c9fo01747j.PubMedUsed to support: Dose-response meta-analysis of 18 trial arms: cocoa flavanols raised flow-mediated dilation by 1.17%, with an inverted-U dose curve peaking near 710 mg flavanols a day. Most studies had risk-of-bias concerns. Nestle-affiliated authors.
- Cocoa flavanol intake improves endothelial function and Framingham Risk Score in healthy men and women: a randomised, controlled, double-masked trial: the Flaviola Health Study. Br J Nutr. 2015;114(8):1246-55. doi: 10.1017/S0007114515002822.PubMedUsed to support: Flaviola trial in 100 healthy adults aged 35 to 60: a cocoa flavanol drink (450 mg twice daily) for 1 month raised flow-mediated dilation by 1.2% and lowered blood pressure and LDL cholesterol compared with a flavanol-free drink. One co-author was affiliated with Mars.
- Assessing the respective contributions of dietary flavanol monomers and procyanidins in mediating cardiovascular effects in humans: randomized, controlled, double-masked intervention trial. Am J Clin Nutr. 2018;108(6):1229-1237. doi: 10.1093/ajcn/nqy229.PubMedUsed to support: Randomized capsule trial in 45 healthy young men: a cocoa extract with 130 mg epicatechin improved flow-mediated dilation and blood pressure over 1 month, while a procyanidin-rich extract with 20 mg epicatechin did not; both lowered total cholesterol. Two co-authors were affiliated with Mars.
- Cardiometabolic Impact of Encapsulated Cocoa Powder and Pure Cocoa Ingredients Supplementation: A Comparative Placebo-Controlled RCT in Adults. Mol Nutr Food Res. 2025;69(5):e202400490. doi: 10.1002/mnfr.202400490.PubMedUsed to support: Randomized 4-week trial in 75 healthy young adults of capsules with flavanol-rich cocoa powder, epicatechin, methylxanthines, both, or placebo: no change in arterial stiffness, blood pressure or lipids in any group.
- Long-Term Effect of Cocoa Extract Supplementation on Incident Hypertension. Hypertension. 2025;82(10):1653-1662. doi: 10.1161/HYPERTENSIONAHA.125.25209.PubMedUsed to support: COSMOS analysis in 8,905 people without high blood pressure at baseline: over a median 3.4 years, cocoa extract did not reduce new self-reported high blood pressure (HR 0.96). A lower rate was seen only in the subgroup with baseline systolic pressure under 120 mmHg.
- Effects of cocoa extract and a multivitamin on cognitive function: A randomized clinical trial. Alzheimers Dement. 2023;19(4):1308-1319. doi: 10.1002/alz.12767.PubMedUsed to support: COSMOS-Mind, 2,262 older adults over 3 years: cocoa extract (500 mg flavanols a day) had no effect on global cognition (P = 0.28); the multivitamin arm showed a small benefit.
- Dietary flavanols restore hippocampal-dependent memory in older adults with lower diet quality and lower habitual flavanol consumption. Proc Natl Acad Sci U S A. 2023;120(23):e2216932120. doi: 10.1073/pnas.2216932120.PubMedUsed to support: COSMOS-Web, 3,562 older adults: the prespecified primary memory outcome at 1 year was not significant for cocoa extract; memory improved only in subgroups with lower habitual diet quality or flavanol intake. Two authors were Mars employees.
- Effect of cocoa extract supplementation on cognitive function: results from the clinic subcohort of the COSMOS trial. Am J Clin Nutr. 2024;119(1):39-48. doi: 10.1016/j.ajcnut.2023.10.031.PubMedUsed to support: COSMOS-Clinic, 573 older adults with in-person testing: 2 years of cocoa extract (500 mg flavanols a day) had no effect on global cognition, episodic memory or executive function; possible benefit in those with poorer diet quality was not corrected for multiple testing.
- Cocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: the Cocoa, Cognition, and Aging (CoCoA) Study--a randomized controlled trial. Am J Clin Nutr. 2015;101(3):538-48. doi: 10.3945/ajcn.114.092189.PubMedUsed to support: 8-week double-blind trial in 90 cognitively intact older adults of cocoa drinks with 993, 520 or 48 mg flavanols a day: no difference in MMSE, but faster Trail Making times and better verbal fluency at the higher doses, plus lower insulin resistance and blood pressure. One co-author was affiliated with Mars.
- Cocoa Extract Supplementation and Risk of Type 2 Diabetes: The Cocoa Supplement and Multivitamin Outcomes Study (COSMOS) Randomized Clinical Trial. Diabetes Care. 2023;46(12):2278-2284. doi: 10.2337/dc23-1012.PubMedUsed to support: COSMOS analysis in 18,381 people without diabetes: a median 3.5 years of cocoa extract (500 mg flavanols a day) did not reduce new self-reported type 2 diabetes (HR 1.04, P = 0.58).
- Impact of alkalization on the antioxidant and flavanol content of commercial cocoa powders. J Agric Food Chem. 2008;56(18):8527-33. doi: 10.1021/jf801670p.PubMedUsed to support: Laboratory survey of commercial cocoa powders: total flavanols averaged 34.6 mg/g in natural cocoa, 13.8 mg/g lightly, 7.8 mg/g medium and 3.9 mg/g heavily alkalized (Dutch-processed) cocoa. Lead author from The Hershey Company.
- Survey of commercially available chocolate- and cocoa-containing products in the United States. 2. Comparison of flavan-3-ol content with nonfat cocoa solids, total polyphenols, and percent cacao. J Agric Food Chem. 2009;57(19):9169-80. doi: 10.1021/jf901821x.PubMedUsed to support: Laboratory survey of top-selling US cocoa and chocolate products: epicatechin and catechin per gram ranked cocoa powder above baking chocolate, then dark chocolate and baking chips, then milk chocolate and chocolate syrup, and tracked nonfat cocoa solids. Lead author from The Hershey Company.
- Commission Regulation (EU) 2015/539 of 31 March 2015 authorising a health claim made on foods, other than those referring to the reduction of disease risk and to children's development and health and amending Regulation (EU) No 432/2012. Official Journal of the European Union. 2015;L 88:7 (1 April 2015)..SourceUsed to support: Not PubMed-indexed. EU regulation listing the authorised claim that cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow, at a daily intake of 200 mg cocoa flavanols (DP 1-10), and extending it to capsules or tablets of high-flavanol cocoa extract; initially restricted to the applicant, Barry Callebaut, for five years.